Similar articles for PMID: 18061862

Year	Number of Results
1986	1
1987	1
1988	1
1992	2
1993	4
1994	3
1995	4
1996	6
1997	6
1998	5
1999	9
2000	11
2001	17
2002	21
2003	19
2004	27
2005	31
2006	58
2007	49
2008	33
2009	22
2010	18
2011	21
2012	12
2013	5
2014	8
2015	8
2016	7
2017	9
2018	5
2019	3
2020	1
2022	1
2024	0

1

Hereditary ovarian cancer--assessing risk and prevention strategies.

Pavelka JC, Li AJ, Karlan BY. Pavelka JC, et al. Obstet Gynecol Clin North Am. 2007 Dec;34(4):651-65, vii-viii. doi: 10.1016/j.ogc.2007.09.005. Obstet Gynecol Clin North Am. 2007. PMID: 18061862 Review.

2

Intra-abdominal carcinomatosis after prophylactic oophorectomy in women of hereditary breast ovarian cancer syndrome kindreds associated with BRCA1 and BRCA2 mutations.

Casey MJ, Synder C, Bewtra C, Narod SA, Watson P, Lynch HT. Casey MJ, et al. Gynecol Oncol. 2005 May;97(2):457-67. doi: 10.1016/j.ygyno.2005.01.039. Gynecol Oncol. 2005. PMID: 15863145

3

Prophylactic oophorectomy in BRCA1 and BRCA2 mutation carriers.

Rebbeck TR. Rebbeck TR. J Clin Oncol. 2000 Nov 1;18(21 Suppl):100S-3S. J Clin Oncol. 2000. PMID: 11060335 Review.

4

Prophylactic oophorectomy in women at increased cancer risk.

Domchek SM, Rebbeck TR. Domchek SM, et al. Curr Opin Obstet Gynecol. 2007 Feb;19(1):27-30. doi: 10.1097/GCO.0b013e32801195da. Curr Opin Obstet Gynecol. 2007. PMID: 17218848 Review.

5

Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations.

Rebbeck TR, Lynch HT, Neuhausen SL, Narod SA, Van't Veer L, Garber JE, Evans G, Isaacs C, Daly MB, Matloff E, Olopade OI, Weber BL; Prevention and Observation of Surgical End Points Study Group. Rebbeck TR, et al. N Engl J Med. 2002 May 23;346(21):1616-22. doi: 10.1056/NEJMoa012158. Epub 2002 May 20. N Engl J Med. 2002. PMID: 12023993 Free article.

6

Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation.

Kauff ND, Satagopan JM, Robson ME, Scheuer L, Hensley M, Hudis CA, Ellis NA, Boyd J, Borgen PI, Barakat RR, Norton L, Castiel M, Nafa K, Offit K. Kauff ND, et al. N Engl J Med. 2002 May 23;346(21):1609-15. doi: 10.1056/NEJMoa020119. Epub 2002 May 20. N Engl J Med. 2002. PMID: 12023992 Free article.

7

Prevention and therapy for BRCA1/2 mutation carriers and women at high risk for breast and ovarian cancer.

Kuschel B, Lux MP, Goecke TO, Beckmann MW. Kuschel B, et al. Eur J Cancer Prev. 2000 Jun;9(3):139-50. Eur J Cancer Prev. 2000. PMID: 10954253 Review.

8

Strategies for ovarian cancer prevention.

Dann RB, Kelley JL, Zorn KK. Dann RB, et al. Obstet Gynecol Clin North Am. 2007 Dec;34(4):667-86, viii. doi: 10.1016/j.ogc.2007.10.001. Obstet Gynecol Clin North Am. 2007. PMID: 18061863 Review.

9

Hereditary ovarian cancer.

Prat J, Ribé A, Gallardo A. Prat J, et al. Hum Pathol. 2005 Aug;36(8):861-70. doi: 10.1016/j.humpath.2005.06.006. Hum Pathol. 2005. PMID: 16112002 Review.

10

Re: "Intra-abdominal carcinomatosis after prophylactic oophorectomy in women of hereditary breast ovarian cancer syndrome kindreds associated with BRCA1 and BRCA2 mutations".

Olivier RI, van Beurden M. Olivier RI, et al. Gynecol Oncol. 2005 Nov;99(2):520-1. doi: 10.1016/j.ygyno.2005.08.013. Epub 2005 Sep 26. Gynecol Oncol. 2005. PMID: 16188301 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

407 results

Results by year